Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy
Status:
Recruiting
Trial end date:
2020-12-10
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the relationship between the vitamin D replacement and
pathological response in patients undergoing neoadjuvant therapy according to different
molecular sub types. Because of no study evaluating pathological response to neoadjuvant
therapy with vitamin D replacement in patients with breast cancer.
Phase:
N/A
Details
Lead Sponsor:
Florence Nightingale Hospital, Istanbul
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins